123Genetix

Curated by Signal

Provider of stem cell based drug discovery and consulting services

Overview

123Genetix is providing stem cell-based drug discovery and consulting services. The platform provides data simulation for disease modeling, biomarker identification, big data analytics, and disease-specific drug discovery among others.

Key facts

Founded: 2017
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

The Better Menopause
Provider of science-backed nutritional supplements to support women in perimenopause and menopause
Life Sciences TechnologyLondon, United Kingdom
HealthSTATS
Radial pulse wave aquisition device for 24-hour blood pressure monitoring
Life Sciences TechnologyLondon, United Kingdom
Research Instruments
Portfolio of medical devices for the field of fertility
Life Sciences TechnologyFalmouth, United Kingdom

About 123Genetix

What does 123Genetix do?

123Genetix is providing stem cell-based drug discovery and consulting services.

Where is 123Genetix headquartered?

123Genetix is headquartered in London, United Kingdom.

When was 123Genetix founded?

123Genetix was founded in 2017.

Which sector is 123Genetix in?

123Genetix operates in Life Sciences Technology.

Who are 123Genetix's competitors?

Companies similar to 123Genetix include The Better Menopause, HealthSTATS, and Research Instruments.